Clinical Trial

Kefir Peptides for Bone Fracture Healing

Study acronym: KPs-Fracture
Completed
View on ClinicalTrials.gov →
Summary
This study is designed to evaluate the effects of kefir-derived peptides on bone healing in patients with upper limb fractures. Kefir peptides are natural protein fragments that may promote bone formation and reduce inflammation. Participants with recent upper limb fractures will be randomly assigned to receive either kefir peptide supplementation or standard treatment. The main purpose of this study is to determine whether kefir peptides can accelerate bone healing and improve recovery compared to standard care.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-09-02; most recent amendment 2026-03-22.
Trial Details
NCT Number NCT07166458
Lead Sponsor Jen-Chieh Lai
Conditions Bone Fractures
Enrollment 30 participants
Start Date 2020-04-13
Primary Completion 2024-07-20 (estimated)
Study Completion 2025-04-20 (estimated)
Updated on ClinicalTrials.gov 2026-03-24